Biohaven Ltd. BHVN
Set alert
15.40 USD +0.24 +1.58%
As of Nov 3, 1:26 PM ET
15.27 Day range 16.09
7.48 52-week range 18.24
- YTD
- +36.40%
- 1 year
- +3.70%
- Open
- 15.46
- Prev close
- 15.16
- Mkt cap
- 2.33B
- Vol
- 997.33K
- Avg vol
- 3.18M
- EPS
- -3.77
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.27
- High
- 16.09
- Forward P/E
- -8.11
- Beta
- 3.13
- Short ratio
- 7.20
- Inst. own
- 95.74%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 1, 2027
- 50-d avg
- 13.62
- 200-d avg
- 12.23
- 1y target
- 23.33
MAX chart
Events in this range
- Nov 10, 2025Earnings: -1.64; estimate -1.91; surprise 14.14%
- Mar 2, 2026Earnings: -1.21; estimate -1.22; surprise 0.82%
- May 4, 2026Earnings: -0.88; estimate -0.86; surprise -2.33%
- Aug 10, 2026Earnings: -0.91; estimate -0.76098; surprise -19.58%
- Aug 11, 2026Rating: RBC Capital · Outperform → Outperform
- Aug 12, 2026Rating: Morgan Stanley · Overweight → Overweight
- Sep 8, 2026Downgrade: RBC Capital · Outperform → Sector Perform
- Sep 10, 2026Rating: HC Wainwright & Co. · Neutral → Neutral
- Oct 23, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 29, 2026Earnings: -0.86; estimate -0.78333; surprise -9.79%
- Oct 30, 2026Rating: Canaccord Genuity · Buy → Buy
Signals (68)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
Newest 20 of 68.
Analyst view
Consensus: buy
Buy
Price target (mean) 23.33 +51.5% upside
Now 15.40
- Target (low)
- 9.00
- Target (mean)
- 23.33
- Target (high)
- 48.00
Ratings (0m) 17 12 buy · 4 hold · 1 sell
- Strong buy3
- Buy9
- Hold4
- Sell0
- Strong sell1
Recommendation trend
- This month 17
- 1 month ago 17
- 2 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.1691 | -0.67 – 1.55 | -0.90 | +81.2% | 86.43M | 0.0% | 6 |
| Next quarter | -0.46 | -0.46 – -0.46 | -0.69 | +33.3% | 11.72M | 0.0% | 1 |
| Current year | -1.76 | -2.88 – -0.41 | -5.55 | +68.4% | 111.43M | 0.0% | 6 |
| Next year | -1.79 | -2.62 – -1.21 | -1.76 | -2.2% | 76.03M | -31.8% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 23, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Sep 10, 2026 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Sep 8, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Aug 12, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 11, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 29, 2026 | B of A Securities | Downgrade | Neutral | Underperform |
| May 26, 2026 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| May 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 11, 2026 | TD Cowen | Maintained | Buy | Buy |
| Mar 4, 2026 | HC Wainwright & Co. | Maintained | Neutral | Neutral |
| Mar 3, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 21, 2026 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Jan 6, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Dec 26, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Dec 3, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 26, 2025 | UBS | Downgrade | Buy | Neutral |
| Nov 20, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 18, 2025 | BTIG | Reiterated | Buy | Buy |
| Nov 13, 2025 | Citigroup | Maintained | Buy | Buy |
| Nov 6, 2025 | Bernstein | Downgrade | Outperform | Market Perform |
| Nov 6, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 6, 2025 | BTIG | Maintained | Buy | Buy |
| Nov 5, 2025 | William Blair | Downgrade | Outperform | Market Perform |
| Nov 5, 2025 | TD Cowen | Maintained | Buy | Buy |
| Sep 17, 2025 | Citigroup | Initiated | — | Buy |
| Sep 16, 2025 | UBS | Maintained | Buy | Buy |